Artículos por temáticas

The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease

Grizzanti J, Lee HG, Camins A, Pallas M, Casadesus G.

Nutr Res. 2016 Dec;36(12):1305-1315. doi: 10.1016/j.nutres.2016.11.002. Epub 2016 Nov 8.

Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing

Hodes RJ, Buckholtz N.

Expert Opin Ther Targets. 2016;20(4):389-91. doi: 10.1517/14728222.2016.1135132. Epub 2016 Feb 7.

Serum Testosterone and Cognitive Function in Ageing Male: Updating the Evidence

Giagulli VA, Guastamacchia E, Licchelli B, Triggiani V.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):22-30. doi: 10.2174/1872214810999160603213743.

Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease

Hernandez L, Ozen A, DosSantos R, Getsios D.

Pharmacoeconomics. 2016 Jul;34(7):681-707. doi: 10.1007/s40273-016-0392-1.

Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy

Liu J, Yang B, Ke J, Li W, Suen WC.

Drugs Aging. 2016 Oct;33(10):685-697. doi: 10.1007/s40266-016-0406-x.

Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs

Zhang XZ, Qian SS, Zhang YJ, Wang RQ.

Pharm Biol. 2016;54(1):18-24. doi: 10.3109/13880209.2015.1027408. Epub 2015 Apr 10.

AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease

Wang Y, Wang H, Chen HZ.

Curr Neuropharmacol. 2016;14(4):364-75. doi: 10.2174/1570159x14666160119094820.

Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs as Alzheimer's disease therapies: an updated umbrella review of systematic reviews and meta-analyses

Wang CH, Wang LS, Zhu N.

Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4801-4817.

Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium

Seripa D, Solfrizzi V, Imbimbo BP, Daniele A, Santamato A, Lozupone M, Zuliani G, Greco A, Logroscino G, Panza F.

Expert Rev Neurother. 2016;16(3):259-77. doi: 10.1586/14737175.2016.1140039.

Withanolides: Biologically Active Constituents in the Treatment of Alzheimer's Disease

Khan SA, Khan SB, Shah Z, Asiri AM.

Med Chem. 2016;12(3):238-56. doi: 10.2174/1573406411666151030112314.

Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer's Disease Therapy

Li L, Zhang L, Yang CC.

Curr Top Med Chem. 2016;16(5):537-48. doi: 10.2174/1568026615666150813144003.

Re-engineering therapeutic antibodies for Alzheimer's disease as blood-brain barrier penetrating bi-specific antibodies

Pardridge WM.

Expert Opin Biol Ther. 2016 Dec;16(12):1455-1468. doi: 10.1080/14712598.2016.1230195. Epub 2016 Sep 7.

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)

Singh NA, Mandal AK, Khan ZA.

Nutr J. 2016 Jun 7;15(1):60. doi: 10.1186/s12937-016-0179-4.

Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease

Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, Martins RN.

Br J Nutr. 2016 Feb 14;115(3):449-65. doi: 10.1017/S0007114515004687. Epub 2015 Dec 14.

Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation

Aaseth J, Alexander J, Bjørklund G, Hestad K, Dusek P, Roos PM, Alehagen U.

Biometals. 2016 Oct;29(5):827-39. doi: 10.1007/s10534-016-9959-8. Epub 2016 Aug 16.